2m 2m 2m 2m 2m 2m 2m
Inhibitor Therpt (INTI)
OTC
$0.08+$0.001 (+1.27%)
Price as of Nov 10, 2026- $14.1MMarket Cap
- 60.19%1-Year Change
- BiotechnologyIndustry
Inhibitor Therpt (INTI)
$0.08+$0.001 (+1.27%)
INTI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.08 | ||
Change | +$0.001 (+1.27%) | ||
Open | $0.08 | ||
High | $0.08 | ||
Low | $0.08 | ||
Previous Close | $0.08 | ||
Volume | 125,000 | ||
30-Day Average Volume | 25,727 | ||
1-Week Change | 1.27% | ||
1-Month Change | -18.37% | ||
1-Year Change | 60.19% | ||
3-Year Change | -54.29% | ||
5-Year Change | -99.10% | ||
Fundamentals | |||
Shares Outstanding | 172.6M | ||
Total Assets | $637,190.00 | ||
Market Cap | $14.1M | ||
Enterprise Value | $13.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$775,220.00 | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $411,912.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | -6 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||